What can the dialysis physician learn from kinetic modelling beyond Kt/Vurea?

Nephrology Dialysis Transplantation

Volumn 27, Issue 11, 2012, Pages 4021-4029

  Eloot, Sunny ^a   Schneditz, Daniel ^b   Vanholder, Raymond ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

compartments; distribution volume; kinetics; middle molecules; protein bound; small solutes

Indexed keywords

BETA 2 MICROGLOBULIN; CREATINE; CREATININE; GUANIDINE; GUANIDINE DERIVATIVE; GUANIDINOACETIC ACID; GUANIDINOSUCCINIC ACID; IMMUNOGLOBULIN LIGHT CHAIN; IODINE; METHYLGUANIDINE; PHOSPHATE; UREA;

ARTICLE; BLOOD FLOW; BODY WATER; COMPARTMENT MODEL; DIALYSATE LEVEL; FLOW KINETICS; HEART OUTPUT; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; KIDNEY PERFUSION; MATHEMATICAL MODEL; MEMBRANE PERMEABILITY; PHYSICIAN; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SIMULATION; SOLUTE; UREMIA;

HUMANS; KINETICS; MODELS, BIOLOGICAL; PHYSICIANS; RENAL DIALYSIS; UREA;

EID: 84869476821     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs367     Document Type: Article

References (64)

1. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993; 4:1205-1213.
2. Daugirdas JT, Schneditz D. Overestimation of hemodialysis dose depends on dialysis efficiency by regional blood flow but not by conventional two pool urea kinetic analysis. ASAIO J 1995; 41: M719-M724.
3. Bloembergen WE, Stannard DC, Port FK et al. Relationship of dose of hemodialysis and cause-specific mortality. Kidney Int 1996; 50:557-565. (Pubitemid 26274385)
4. Nissenson AR, Owen WF, Jr. Ownership of dialysis facilities and patients' survival. N Engl J Med 2000; 342:1054-1055.
5. Saran R, Bragg-Gresham JL, Levin NW et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 2006; 69:1222-1228.
6. Eknoyan G, Beck GJ, Cheung AK et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347:2010-2019. (Pubitemid 35461657)
7. Paniagua R, Amato D, Vonesh E et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13:1307-1320. (Pubitemid 34441412)
8. Dedrick RL, Gabelnick HL, Bischoff KB. Kinetics of urea distribution. Proc XXI EMBS 1968; 10:31.
9. Dedrick RL, Bisschoff KB. Pharmacokinetics in applications of the artificial kidney. Chem Eng Prog Symp Ser 1968; 64:32-44.
10. Forbes GB. Human Body Composition; Growth Aging, Nutrition, and Activity. New York: Springer Verlag, 1987.
11. Sapirstein LA. Regional blood flow by fractional distribution of indicators. Al J Physiol 1958; 193:161-168.
12. Widdowson EM, Dickerson JWT. Chapter 17. In: Comar CL, Bronner F (eds). Chemical Composition of the Body. New York: Academic Press, 1964.
13. Schneditz D, Platzer D, Daugirdas JT. A diffusion-adjusted regional blood flow model to predict solute kinetics during haemodialysis. Nephrol Dial Transplant 2009; 24:2218-2224.
14. Coleman TG, Manning RD, Jr, Norman RA, Jr et al. Dynamics of water-isotope distribution. Am J Physiol 1972; 223:1371-1375.
15. Schneditz D, Van Stone JC, Daugirdas JT. A regional blood circulation alternative to in-series two compartment urea kinetic modeling. ASAIO J 1993; 39: M573-M577. (Pubitemid 23311763)
16. Zhao D, Sonawane ND, Levin MH et al. Comparative transport efficiencies of urea analogues through urea transporter UT-B. Biochim Biophys Acta 2007; 1768:1815-1821. (Pubitemid 46900809)
17. Grandi F, Avanzolini G, Cappello A. Analytic solution of the variable-volume double-pool urea kinetics model applied to parameter estimation in hemodialysis. Comput Biol Med 1995; 25:505-518.
18. Schneditz D, Daugirdas JT. Formal analytical solution to a regional blood flow and diffusion based urea kinetic model. ASAIO J 1994; 40: M667-M673. (Pubitemid 24364286)
19. Eloot S, Torremans A, De Smet R et al. Complex compartmental behavior of small water-soluble uremic retention solutes: evaluation by direct measurements in plasma and erythrocytes. Am J Kidney Dis 2007; 50:279-288. (Pubitemid 47095079)
20. Eloot S, Torremans A, De Smet R et al. Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds. Kidney Int 2005; 67:1566-1575. (Pubitemid 40463137)
21. Carson E, Cobelli C. An introduction to modelling methodology. In: Carson E, Coballi C (eds). Modelling Methodology for Physiology and Medicine. New York: Academic Press, 2001, 1-13.
22. Vanholder R, De Smet R, Glorieux G et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63:1934-1943. (Pubitemid 36513344)
23. Ciandrini A, Severi S, Cavalcanti S et al. Model-based analysis of potassium removal during hemodialysis. Artif Organs 2009; 33:835-843.
24. Di Filippo S, Corti M, Andrulli S et al. Determining the adequacy of sodium balance in hemodialysis using a kinetic model. Blood Purif 1996; 14:431-436. (Pubitemid 126447891)
25. Fernandez PC, Cohen RM, Feldman GM. The concept of bicarbonate distribution space: the crucial role of body buffers. Kidney Int 1989; 36:747-752. (Pubitemid 19283271)
26. Gotch F, Levin NW, Kotanko P. Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration. Blood Purif 2010; 29:163-176.
27. Gotch FA, Lam MA, Prowitt M et al. Preliminary clinical results with sodium-volume modeling of hemodialysis therapy. Proc Clin Dial Transplant Forum 1980; 10:12-17.
28. Pedrini LA, Ponti R, Faranna P et al. Sodium modeling in hemodia-filtration. Kidney Int 1991; 40:525-532.
29. Pacitti A, Casino FG, Pedrini L et al. Prescription and surveillance of the acetate-free biofiltration sessions: the bicarbonate cycle. Int J Artif Organs 1995; 18:722-725. (Pubitemid 26035941)
30. Santoro A, Mancini E, Paolini F et al. Blood volume regulation during hemodialysis. Am J Kidney Dis 1998; 32:739-748. (Pubitemid 28516303)
31. Ursino M, Coli L, Brighenti C et al. Mathematical modeling of solute kinetics and body fluid changes during profiled hemodialysis. Int J Artif Organs 1999; 22:94-107. (Pubitemid 29158997)
32. Eloot S, Dhondt A, Hoste E et al. How to remove accumulated iodine in burn-injured patients. Nephrol Dial Transplant 2010; 25:1614-1620.
33. Pietsch J, Meakins JL. Complications of povidone-iodine absorption in topically treated burn patients. Lancet 1976; 1:280-282.
34. Scoggin C, McClellan JR, Cary JM. Hypernatraemia and acidosis in association with topical treatment of burns. Lancet 1977; 1:959. (Pubitemid 8092482)
35. Kanakiriya S, De Chazal I, Nath KA et al. Iodine toxicity treated with hemodialysis and continuous venovenous hemodiafiltration. Am J Kidney Dis 2003; 41:702-708. (Pubitemid 36278391)
36. Matzkies FK, Reinecke H, Tombach B et al. Influence of dialysis procedure, membrane surface and membrane material on iopromide elimination in patients with reduced kidney function. Am J Nephrol 2000; 20:300-304.
37. D'Hooge R, De Deyn PP, Van de Vijver G et al. Uraemic guanidino compounds inhibit gamma-aminobutyric acid-evoked whole cell currents in mouse spinal cord neurones. Neurosci Lett 1999; 265:83-86. (Pubitemid 29210374)
38. MacAllister RJ, Whitley GS, Vallance P. Effects of guanidino and uremic compounds on nitric oxide pathways. Kidney Int 1994; 45:737-742. (Pubitemid 24094485)
39. Glorieux GL, Dhondt AW, Jacobs P et al. In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection. Kidney Int 2004; 65:2184-2192. (Pubitemid 38670004)
40. Horowitz HI, Cohen BD, Martinez P et al. Defective ADP-induced platelet factor 3 activation in uremia. Blood 1967; 30:331-340.
41. Giovannetti S, Cioni L, Balestri PL et al. Evidence that guanidines and some related compounds cause haemolysis in chronic uraemia. Clin Sci 1968; 34:141-148.
42. Schneditz D, Yang Y, Christopoulos G et al. Rate of creatinine equilibration in whole blood. Hemodial Int 2009; 13:215-221.
43. Eloot S, Van Biesen W, Dhondt A et al. Impact of increasing hae-modialysis frequency versus haemodialysis duration on removal of urea and guanidino compounds: a kinetic analysis. Nephrol Dial Transplant 2009; 24:2225-2232.
44. Spalding EM, Chamney PW, Farrington K. Phosphate kinetics during hemodialysis: evidence for biphasic regulation. Kidney Int 2002; 61:655-667. (Pubitemid 34102609)
45. Leypoldt JK. Kinetics of beta2-microglobulin and phosphate during hemodialysis: effects of treatment frequency and duration. Semin Dial 2005; 18:401-408. (Pubitemid 41545875)
46. Agar BU, Akonur A, Lo YC et al. Kinetic model of phosphorus mobilization during and after short and conventional hemodialysis. Clin J Am Soc Nephrol 2011; 6:2854-2860.
47. Maheshwari V, Samavedham L, Rangaiah GP. A regional blood flow model for beta2-microglobulin kinetics and for simulating intra-dia-lytic exercise effect. Ann Biomed Eng 2011; 39:2879-2890.
48. Leypoldt JK, Cheung AK, Deeter RB. Rebound kinetics of beta2-microglobulin after hemodialysis. Kidney Int 1999; 56:1571-1577.
49. Sugisaki H, Onohara M, Kunitomo T. Phosphate in dialysis patients. Trans Am Soc Artif Intern Organs 1983; 29:38-43.
50. Odell RA, Slowiaczek P, Moran JE et al. Beta 2-microglobulin kinetics in end-stage renal failure. Kidney Int 1991; 39:909-919.
51. Stiller S, Xu XQ, Gruner N et al. Validation of a two-pool model for the kinetics of beta2-microglobulin. Int J Artif Organs 2002; 25:411-420.
52. Clark WR, Leypoldt JK, Henderson LW et al. Quantifying the effect of changes in the hemodialysis prescription on effective solute removal with a mathematical model. J Am Soc Nephrol 1999; 10:601-609. (Pubitemid 29117642)
53. Hutchison CA, Cockwell P, Reid S et al. Efficient removal of immu-noglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies. J Am Soc Nephrol 2007; 18:886-895. (Pubitemid 46434505)
54. Luo FJ, Patel KP, Marquez IO et al. Effect of increasing dialyzer mass transfer area coefficient and dialysate flow on clearance of protein-bound solutes: a pilot crossover trial. Am J Kidney Dis 2009; 53:1042-1049.
55. Meyer TW, Leeper EC, Bartlett DW et al. Increasing dialysate flow and dialyzer mass transfer area coefficient to increase the clearance of protein-bound solutes. J Am Soc Nephrol 2004; 15:1927-1935. (Pubitemid 38822074)
56. Meyer TW, Sirich TL, Hostetter TH. Dialysis cannot be dosed. Semin Dial 2011; 24:471-479.
57. Jung A, Krisper P, Haditsch B et al. Bilirubin kinetic modeling for quantification of extracorporeal liver support. Blood Purif 2006; 24:413-422. (Pubitemid 44215188)
58. Jung A, Korohoda P, Krisper P et al. Relationship between kinetics of albumin-bound bilirubin and water-soluble urea in extracorporeal blood purification. Nephrol Dial Transplant 2012; 27:1200-1206.
59. Meyer TW, Walther JL, Pagtalunan ME et al. The clearance of protein-bound solutes by hemofiltration and hemodiafiltration. Kidney Int 2005; 68:867-877. (Pubitemid 43323146)
60. Mohan S, Madhrira M, Mujtaba M et al. Effective ionic dialysance/blood flow rate ratio: an indicator of access recirculation in arteriove-nous fistulae. ASAIO J 2010; 56:427-433.
61. Eloot S, Vanholder R, Van Biesen W et al. The patient as a limit to dialysis technology. Clin J Am Soc Nephrol 2011; 6:2105-2107.
62. Leypoldt JK, Jaber BL, Lysaght MJ et al. Kinetics and dosing predictions for daily haemofiltration. Nephrol Dial Transplant 2003; 18:769-776. (Pubitemid 36432260)
63. Basile C, Lomonte C. Kt/V urea does not tell it all. Nephrol Dial Transplant 2012; 27:1284-1287.
64. Maasrani M, Jaffrin MY, Fischbach M et al. Urea, creatinine and phosphate kinetic modeling during dialysis: application to pediatric hemodialysis. Int J Artif Organs 1995; 18:122-129.